Page last updated: 2024-10-21

mercaptoethanol and Bladder Cancer

mercaptoethanol has been researched along with Bladder Cancer in 9 studies

Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.

Research Excerpts

ExcerptRelevanceReference
"The influence of sodium-2-mercaptoethanesulphonate (Mesna) on urinary bladder cancer induced by N-nitroso-N-butyl-N-(4-hydroxybutyl)amine (BBNOH) was studied in male Sprague-Dawley rats."7.67Delay of bladder cancer induction in rats treated with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine by administration of sodium-2-mercaptoethanesulfonate (Mesna). ( Habs, M; Schmähl, D; Tacchi, AM, 1984)
"The influence of sodium-2-mercaptoethanesulphonate (Mesna) on urinary bladder cancer induced by N-nitroso-N-butyl-N-(4-hydroxybutyl)amine (BBNOH) was studied in male Sprague-Dawley rats."3.67Delay of bladder cancer induction in rats treated with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine by administration of sodium-2-mercaptoethanesulfonate (Mesna). ( Habs, M; Schmähl, D; Tacchi, AM, 1984)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19908 (88.89)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shaw, IC1
Rose, JW1
Habs, MR2
Schmähl, D5
Tacchi, AM2
Habs, M2
Pinto, V1
Fernandez-Fuertes, F1
Cecchini, C1
Soto, I1
Barez, A1
Kanda, S1
Takahashi, M1
Nagase, S1
Berger, MR1
Brock, N1
Pohl, J1

Other Studies

9 other studies available for mercaptoethanol and Bladder Cancer

ArticleYear
Infusion of ifosphamide plus mesna.
    Lancet (London, England), 1984, Jun-16, Volume: 1, Issue:8390

    Topics: Cyclophosphamide; Drug Interactions; Humans; Ifosfamide; Infusions, Parenteral; Mercaptoethanol; Mes

1984
Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
    Cancer, 1983, Feb-15, Volume: 51, Issue:4

    Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Male; Mercaptoethanol; Mesna; Neoplasms

1983
Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Animals; Cyclophosphamide; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Urinary Bladder

1983
Delay of bladder cancer induction in rats treated with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine by administration of sodium-2-mercaptoethanesulfonate (Mesna).
    Cancer letters, 1984, Volume: 22, Issue:1

    Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Drinking; Lung Neoplasms; Male; Mer

1984
[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
    Der Urologe. Ausg. A, 1984, Volume: 23, Issue:5

    Topics: Animals; Carcinoma, Transitional Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Female; M

1984
11-Oxycorticosteroid-dependent antibody in the serum of a patient with bladder neoplasm.
    Vox sanguinis, 1992, Volume: 63, Issue:3

    Topics: Adrenal Cortex Hormones; Adsorption; Aged; Antibodies, Neoplasm; Antigen-Antibody Complex; Blood Tra

1992
Fluorometric assay for polyamines in urine and tissues using electrophoresis on Titan III cellulose acetate.
    Analytical biochemistry, 1989, Aug-01, Volume: 180, Issue:2

    Topics: Animals; Cellulose; Chromatography, High Pressure Liquid; Electrophoresis; Fluorometry; Hydrogen-Ion

1989
Delayed development of bladder cancer in male SD rats induced with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine following concomitant administration of sodium 2-mercaptoethane sulfonate.
    Cancer letters, 1986, Volume: 32, Issue:3

    Topics: Animals; Butylhydroxybutylnitrosamine; Male; Mercaptoethanol; Mesna; Neoplasm Metastasis; Rats; Urin

1986
Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    IARC scientific publications, 1986, Issue:78

    Topics: Animals; Biotransformation; Cyclophosphamide; DNA; Glutathione; Ifosfamide; Kidney; Leukemia, Experi

1986